Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joachim Diebold

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
JTO Clinical and Research Reports|September 30, 2021
Intracranial Activity of Osimertinib Plus Capmatinib in a Patient With <i>EGFR</i> and <i>MET</i>-Driven Lung Cancer: Case ReportOliver Gautschi, Joachim Diebold
Oncogene|October 19, 2004
Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expressionDimitri Lodygin, Joachim Diebold, Heiko Hermeking
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 21, 2003
K-RAS mutations in ovarian and extraovarian lesions of serous tumors of borderline malignancyJoachim Diebold, Florian Seemüller, Udo Löhrs
European Journal of Cancer (Oxford, England : 1990)|February 22, 2011
Mutational spectrum and therapy response of metastasized GIST in Central Switzerland - a population-based studyMatthias Rössle, Astrid Hirschmann, Joachim Diebold
American Journal of Clinical Pathology|December 11, 2002
CAS (cellular apoptosis susceptibility) gene expression in ovarian carcinoma: Correlation with 20q13.2 copy number and cyclin D1, p53, and Rb protein expressionGloria Peiró, Joachim Diebold, Udo Löhrs
Current Opinion in Oncology|November 6, 2018
Treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer: update and perspectivesChristoph Oliver Ryser, Joachim Diebold, Oliver Gautschi
American Journal of Clinical Pathology|July 18, 2003
Insulin-like growth factor-I receptor and PTEN protein expression in endometrial carcinoma. Correlation with bax and bcl-2 expression, microsatellite instability status, and outcomeGloria Peiró, Peter Lohse, Doris Mayr, et al.
Virchows Archiv : an International Journal of Pathology|January 15, 2008
Molecular genetic aberrations of ovarian and uterine carcinosarcomas--a CGH and FISH studyAlexander Schipf, Doris Mayr, Thomas Kirchner, et al.
Gynecologic Oncology|June 30, 2006
KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implantsDoris Mayr, Astrid Hirschmann, Udo Löhrs, et al.
The American Journal of Pathology|January 28, 2003
Multicolor deconvolution microscopy of thick biological specimensChristine Maierhofer, Rainer Gangnus, Joachim Diebold, et al.
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
JTO Clinical and Research Reports|September 30, 2021
Intracranial Activity of Osimertinib Plus Capmatinib in a Patient With <i>EGFR</i> and <i>MET</i>-Driven Lung Cancer: Case ReportOliver Gautschi, Joachim Diebold
Oncogene|October 19, 2004
Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expressionDimitri Lodygin, Joachim Diebold, Heiko Hermeking
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 21, 2003
K-RAS mutations in ovarian and extraovarian lesions of serous tumors of borderline malignancyJoachim Diebold, Florian Seemüller, Udo Löhrs
European Journal of Cancer (Oxford, England : 1990)|February 22, 2011
Mutational spectrum and therapy response of metastasized GIST in Central Switzerland - a population-based studyMatthias Rössle, Astrid Hirschmann, Joachim Diebold
American Journal of Clinical Pathology|December 11, 2002
CAS (cellular apoptosis susceptibility) gene expression in ovarian carcinoma: Correlation with 20q13.2 copy number and cyclin D1, p53, and Rb protein expressionGloria Peiró, Joachim Diebold, Udo Löhrs
Current Opinion in Oncology|November 6, 2018
Treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer: update and perspectivesChristoph Oliver Ryser, Joachim Diebold, Oliver Gautschi
American Journal of Clinical Pathology|July 18, 2003
Insulin-like growth factor-I receptor and PTEN protein expression in endometrial carcinoma. Correlation with bax and bcl-2 expression, microsatellite instability status, and outcomeGloria Peiró, Peter Lohse, Doris Mayr, et al.
Virchows Archiv : an International Journal of Pathology|January 15, 2008
Molecular genetic aberrations of ovarian and uterine carcinosarcomas--a CGH and FISH studyAlexander Schipf, Doris Mayr, Thomas Kirchner, et al.
Gynecologic Oncology|June 30, 2006
KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implantsDoris Mayr, Astrid Hirschmann, Udo Löhrs, et al.
The American Journal of Pathology|January 28, 2003
Multicolor deconvolution microscopy of thick biological specimensChristine Maierhofer, Rainer Gangnus, Joachim Diebold, et al.
Pageof 10